A recent survey found that 21% of caregivers expressed hesitancy to vaccinate themselves and 29% of expressed hesitancy to have...
Ficlatuzumab (AV-299) in combination with cytarabine (ara-C), demonstrates signs of clinical efficacy in patients with r/r AML....
Researchers at Baylor College of Medicine, the Broad Institute of MIT, and Harvard have applied powerful proteogenomics approaches to better understand the biological...